Submit a comment

Tolerance to solid organ transplants through transfer of MHC class II genes
Kai-C. Sonntag, … , David H. Sachs, Christian LeGuern
Kai-C. Sonntag, … , David H. Sachs, Christian LeGuern
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):65-71. https://doi.org/10.1172/JCI11015.
View: Text | PDF
Article Article has an altmetric score of 3

Tolerance to solid organ transplants through transfer of MHC class II genes

Abstract

Donor/recipient MHC class II matching permits survival of experimental allografts without permanent immunosuppression, but is not clinically applicable due to the extensive polymorphism of this locus. As an alternative, we have tested a gene therapy approach in a preclinical animal model to determine whether expression of allogeneic class II transgenes (Tg’s) in recipient bone marrow cells would allow survival of subsequent Tg-matched renal allografts. Somatic matching between donor kidney class II and the recipient Tg’s, in combination with a short treatment of cyclosporine A, prolonged graft survival with DR and promoted tolerance with DQ. Class II Tg expression in the lymphoid lineage and the graft itself were sequentially implicated in this tolerance induction. These results demonstrate the potential of MHC class II gene transfer to permit tolerance to solid organ allografts.

Authors

Kai-C. Sonntag, David W. Emery, Akihiko Yasumoto, Gary Haller, Sharon Germana, Tomasz Sablinski, Akira Shimizu, Kazuhiko Yamada, Hideaki Shimada, Scott Arn, David H. Sachs, Christian LeGuern

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required
Rich Text Editor, eletter_body